Fan Yao

Shenzhen Branch
Shenzhen, 518000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: September 03, 2026

Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Journal: Nature communications

Published: April 22, 2026

Liproxstatin-1 improves functional recovery after acute spinal cord injury by inhibiting ferroptosis-induced inflammation.

Liproxstatin-1 improves functional recovery after acute spinal cord injury by inhibiting ferroptosis-induced inflammation.

Journal: Molecular and cellular neurosciences

Published: December 29, 2025

PlantGFM: A Genomic Foundation Model for Discovery and Creation of Plant Genes.

PlantGFM: A Genomic Foundation Model for Discovery and Creation of Plant Genes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 15, 2025

Copper-Induced Thyroid Disruption and Oxidative Stress in Schizopygopsis younghusbandi Larvae.

Copper-Induced Thyroid Disruption and Oxidative Stress in Schizopygopsis younghusbandi Larvae.

Journal: Antioxidants (Basel, Switzerland)

Published: November 28, 2025

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis.

Journal: Journal for immunotherapy of cancer

Published: July 19, 2025

PKCα-mediated nuclear translocation of cGAS stabilizes β-catenin and drives metastasis.

PKCα-mediated nuclear translocation of cGAS stabilizes β-catenin and drives metastasis.

Journal: Molecular cell

Published: July 15, 2025

In vivo CRISPR activation screen identifies acyl-CoA-binding protein as a driver of bone metastasis.

In vivo CRISPR activation screen identifies acyl-CoA-binding protein as a driver of bone metastasis.

Journal: Science translational medicine

Published: May 21, 2025

ASSOCIATION BETWEEN OBESITY AND BRAFV600E MUTATION IN PAPILLARY THYROID CARCINOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.

ASSOCIATION BETWEEN OBESITY AND BRAFV600E MUTATION IN PAPILLARY THYROID CARCINOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)

Published: April 01, 2025

Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Journal: Nature communications

Published: September 26, 2024

Author Correction: Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis.

Author Correction: Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis.

Journal: Nature communications

Published: June 10, 2024

Barriers and opportunities in pancreatic cancer immunotherapy.

Barriers and opportunities in pancreatic cancer immunotherapy.

Journal: NPJ precision oncology

Published: April 01, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026